Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Femasys Inc.

FEMYNASDAQ
Healthcare
Medical - Instruments & Supplies
$0.55
$0.005(0.83%)
U.S. Market opens in 15h 44m

Femasys Inc. Fundamental Analysis

Femasys Inc. (FEMY) shows moderate financial fundamentals with a PE ratio of -0.79, profit margin of -9.61%, and ROE of -7.64%. The company generates $0.0B in annual revenue with strong year-over-year growth of 51.97%.

Key Strengths

Cash Position28.76%
PEG Ratio-0.05

Areas of Concern

ROE-7.64%
Operating Margin-8.58%
We analyze FEMY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1458.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1458.3/100

We analyze FEMY's fundamental strength across five key dimensions:

Efficiency Score

Weak

FEMY struggles to generate sufficient returns from assets.

ROA > 10%
-1.22%

Valuation Score

Excellent

FEMY trades at attractive valuation levels.

PE < 25
-0.79
PEG Ratio < 2
-0.05

Growth Score

Moderate

FEMY shows steady but slowing expansion.

Revenue Growth > 5%
51.97%
EPS Growth > 10%
9.68%

Financial Health Score

Moderate

FEMY shows balanced financial health with some risks.

Debt/Equity < 1
1.85
Current Ratio > 1
1.16

Profitability Score

Weak

FEMY struggles to sustain strong margins.

ROE > 15%
-764.17%
Net Margin ≥ 15%
-9.61%
Positive Free Cash Flow
No

Key Financial Metrics

Is FEMY Expensive or Cheap?

P/E Ratio

FEMY trades at -0.79 times earnings. This suggests potential undervaluation.

-0.79

PEG Ratio

When adjusting for growth, FEMY's PEG of -0.05 indicates potential undervaluation.

-0.05

Price to Book

The market values Femasys Inc. at 3.41 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.41

EV/EBITDA

Enterprise value stands at -0.71 times EBITDA. This is generally considered low.

-0.71

How Well Does FEMY Make Money?

Net Profit Margin

For every $100 in sales, Femasys Inc. keeps $-9.61 as profit after all expenses.

-9.61%

Operating Margin

Core operations generate -8.58 in profit for every $100 in revenue, before interest and taxes.

-8.58%

ROE

Management delivers $-7.64 in profit for every $100 of shareholder equity.

-7.64%

ROA

Femasys Inc. generates $-1.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.22%

Following the Money - Real Cash Generation

Operating Cash Flow

Femasys Inc. generates limited operating cash flow of $-19.97M, signaling weaker underlying cash strength.

$-19.97M

Free Cash Flow

Femasys Inc. generates weak or negative free cash flow of $-20.47M, restricting financial flexibility.

$-20.47M

FCF Per Share

Each share generates $-0.70 in free cash annually.

$-0.70

FCF Yield

FEMY converts -1.27% of its market value into free cash.

-1.27%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.79

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.41

vs 25 benchmark

P/S Ratio

Price to sales ratio

7.69

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.85

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.16

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-7.64

vs 25 benchmark

ROA

Return on assets percentage

-1.22

vs 25 benchmark

ROCE

Return on capital employed

-3.08

vs 25 benchmark

How FEMY Stacks Against Its Sector Peers

MetricFEMY ValueSector AveragePerformance
P/E Ratio-0.7929.43 Better (Cheaper)
ROE-764.17%800.00% Weak
Net Margin-960.53%-20145.00% (disorted) Weak
Debt/Equity1.850.30 Weak (High Leverage)
Current Ratio1.164.64 Neutral
ROA-121.55%-17936.00% (disorted) Weak

FEMY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Femasys Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-7.38%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

11.83%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

6.69%

Industry Style: Defensive, Growth, Innovation

Growing

Fundamental Analysis FAQ